Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice

This publication has 26 references indexed in Scilit:

• Phosphatidylinositol 4‐kinase III beta is the target of oxoglaucine and pachypodol (Ro 09‐0179) for their anti‐poliovirus activities, and is located at upstream of the target step of brefeldin A
  Microbiology and Immunology, 2015
• Selective inhibitors of picornavirus replication
  Medicinal Research Reviews, 2008
• Vaccination against polio should not be stopped
  Nature Reviews Microbiology, 2007
• Antiviral Agents in the Prevention and Treatment of Virus-Induced Diabetes
  Anti-Infective Agents, 2006
• Current Status of Anti-Picornavirus Therapies
  Current Pharmaceutical Design, 2006
• Efficacy and Safety of Oral Pleconaril for Treatment of Colds Due to Picornaviruses in Adults: Results of 2 Double-Blind, Randomized, Placebo-Controlled Trials
  Clinical Infectious Diseases, 2003
• SEVERE NEONATAL ENTEROVIRAL HEPATITIS TREATED WITH PLECONARIL
  The Pediatric Infectious Disease Journal, 2001
• Attenuated Virulence of Pleconaril‐Resistant Coxsackievirus B3 Variants
  The Journal of Infectious Diseases, 1999
• Intranasal pirodavir (R77,975) treatment of rhinovirus colds
  Antimicrobial Agents and Chemotherapy, 1995
• Production of Plaques in Monolayer Tissue Cultures by Single Particles of an Animal Virus
  Proceedings of the National Academy of Sciences, 1952